BPC 157 5mg

BPC-157 (Pentadecapeptide) is a novel stable 15 amino-acid compound that was partially isolated from human gastric juice. It has been used in the treatment of ulcers and several other wounds. It is manufactured as BPC-157 (Pentadecapeptide) 5mg/vial injection containing Pentadecapeptide 5mg and excipients.

BPC-157 (Pentadecapeptide) Mechanism of Action:

BPC-157 (Body Protection Compound – 157) has been shown to protect cells. The 15 amino acids that form this compound do not occur naturally but the compound is a derivative of the human gastric juice. Pentadecapeptide exerts its effect through the process of angiogenesis (blood vessel formation). This process can lead to the formation of a large vascular network, which allows for the regeneration of tissue. BPC-157 has been found to reduce the area of ulceration and help in the regeneration or healing of ulcers. Another mechanism through which it possibly achieves this is by inhibiting a growth-inhibiting factor, 4-hydroxynoneal, thereby allowing more growth and regeneration. BPC-157 (Pentadecapeptide) also protects the stomach lining from toxic agents. Due to its regenerative attributes, it has also been found to stimulate the proliferation of tendon cells and may be useful in regenerating neuronal cells.

BPC-157 (Pentadecapeptide) Dosage:

200 – 400mcg daily, given as intramuscular injections.

BPC-157 (Pentadecapeptide) Side effects:

Pain at the injection site, inflammation, fatigue, dizziness.

BPC-157 (Pentadecapeptide) Interactions:

Nitric oxide, dopamine.